Tumour necrosis factor-α polymorphism as one of the complex inherited factors in pemphigus

Mediators of Inflammation

Volumn 12, Issue 5, 2003, Pages 303-307

  Torzecka, Jolanta Dorota ^a   Narbutt, Joanna ^a   Sysa Jedrzejowska, Anna ^a   Borowiec, Maciej ^a   Ptasinska, Anetta ^a   Woszczek, Grzegorz ^a   Kowatski, Marek L ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

HLA class II; Pemphigus foliaceus; Pemphigus vulgaris; Polish population; Polymorphism tumour necrosis factor

Indexed keywords

HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOSOMAL DOMINANT INHERITANCE; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; POLAND; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

FEMALE; GENE FREQUENCY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

PEMPHIGUS;

EID: 0242693484     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350310001619735     Document Type: Article

References (23)

1. Feliciani C, Toto P, Amerio P, Pour SM, Coscione G, Shivji G, Wang B, Sauder DN. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris; interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol 2000; 114: 71-77.
2. D'Auria L, Bonifati C, Mussi A, et al. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumor necrosis factor-alpha levels a significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Network 1997; 4: 383-387.
3. Ahmed AR, Yunis EJ, Khatri K. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1990; 87: 7658-7662.
4. Ahmed AR, Wagner R, Khatri K. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1991; 88: 5056-5061.
5. Niizeki H, Inoko H, Mizuki N, Inamoto N, Watababe K, Hashimoto T, Nishikawa T. HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method. Tissue Antigens 1994; 44: 248-251.
6. Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T. HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J Invest Dermatol 1997; 109: 615-618.
7. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 2003; 170: 635-642.
8. Moraes ME, Fernandez-Vina M, Lazaro A, et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997; 49: 35-40.
9. Lin MS, Fu CL, Aoki V, et al. Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest 2000; 105: 207-213.
10. Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E, Martin J. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997; 49: 74-78.
11. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-500.
12. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
13. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 2002; 46: 32-41.
14. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154-159.
15. Juszczynski P, Kalinka E, Bienvenu J, et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 2002; 100: 3037-3040.
16. Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 3050-3053.
17. Fabris M, Tolusso B, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli G. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J Rheumatol 2002; 29: 1847-1850.
18. Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001; 2: 363-366.
19. Lombardi ML, Mercuro O, Ruocco V, et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol 1999; 113: 107-110.
20. Miyagawa S, Amagai M, Niizeki H, et al. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 1999; 54: 333-340.
21. Petzl-Erler ML, Santamaria J. Are HLA class II genes controlling susceptibility and resistance to Brazilian pemphigus foliaceus (fogo selvagem)? Tissue Antigens 1989; 33: 408-414.
22. Gonzalez-Escribano MF, Jimenez G, Walter K, et al. Distribution of HLA alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens 1998; 52: 275-278.
23. Birol A, Anadolu RY, Tutkak H, Gurgey E. HLA-class 1 and class 2 antigens in Turkish patients with pemphigus. Int J Dermatol 2002; 41: 79-83.